natgillin/translations-raw huggingface dataset:
Administration of Viani to pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus. 
Uporaba Vianija pri nosečnicah pride v poštev le, če je pričakovana korist za mater večja od vsakega možnega tveganja za plod.
Fluticasone propionate given by inhalation at recommended doses has a glucocorticoid antiinflammatory action within the lungs, resulting in reduced symptoms and exacerbations of asthma, with less adverse effects than when corticosteroids are administered systemically. 
V priporočenih odmerkih inhalirani flutikazonijev propionat ima v pljučih glukokortikoidno protivnetno delovanje; s tem zmanjša simptome in poslabšanja astme z manj neželenimi učinki kot med sistemsko uporabo kortikosteroidov.
It is important that patients start to breathe in as slowly as possible just before operating their inhaler. 
Pomembno je, da začne pred uporabo inhalatorja vdihovati, kolikor je mogoče počasi.
Your doctor will supervise your treatment more closely if you have medical conditions such as heart disease including an irregular or fast heart beat, overactive thyroid gland, high blood pressure, diabetes mellitus (Viani may increase your blood sugar), low potassium in your blood or if you are being, or have been treated for have tuberculosis (TB). 
Bodite posebno pozorni pri uporabi zdravila Viani Zdravnik bo vaše zdravljenje spremljal natančneje, če imate kakšno zdravstveno težavo, npr. bolezen srca (vključno z nerednim ali hitrim srčnim utripom), čezmerno dejavno ščitnico, visok krvni tlak, diabetes mellitus (Viani lahko zviša krvni sladkor), nizek kalij v krvi ali se zdravite oz. ste se zdravili zaradi tuberkuloze.
Viani does not work in controlling sudden attacks of breathlessness and wheezing where you would need to use your fast acting ‘rescue' medication. 
Vendar pa Viani ne more obvladati nenadnih napadov težkega in piskajočega dihanja: v takšnem primeru morate uporabiti hitrodelujoče "olajševalno" zdravilo.
The possible side effects associated with Viani are unlikely to affect your ability to drive or use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi možni neželeni učinki, povezani z Vianijem, neugodno vplivali na vašo sposobnost upravljanja vozil in strojev.
Each time the can is pressed, a puff of medicine is released and the counter will count down by one. 
Vsakič, ko pritisnete pršilnik, se sprosti vdih zdravila, števec pa se pomakne za eno navzdol.
Viani is contraindicated in patients with hypersensitivity to any of the active substances or to the excipient. 
Viani je kontraindiciran pri bolnikih, ki so preobčutljivi za katerokoli zdravilno učinkovino ali pomožno snov.
The container should not be punctured, broken or burnt even when apparently empty. 
Vsebnika se ne sme prebadati, lomiti ali sežigati, tudi če se zdi, da je prazen.
There are no data available for use of Viani in patients with hepatic impairment. 
Podatkov o uporabi Vianija pri bolnikih z okvaro jeter ni.
The canister has a counter attached to it, which shows how many actuations of medicine are left. 
Na pločevinki je nameščen števec, ki kaže, koliko vdihov zdravila je še preostalo.
The pressurised can contains a white to off white suspension for inhalation. 
Pločevinka pod tlakom vsebuje belo do kremasto suspenzijo za inhaliranje.
Never try to alter the numbers on the counter or detach the counter from the metal can. 
Nikdar ne poskušajte spreminjati številk na števcu ali števca sneti s pločevinke.
If you are using high doses of Viani for a long time, one of the active ingredients, fluticasone propionate, may stop the natural production of steroid hormones by the adrenal gland. 
Če dolgo časa uporabljate velike odmerke Vianija, lahko flutikazonijev propionat, ki je ena od obeh zdravilnih učinkovin, zavre naravno nastajanje steroidnih hormonov v nadledvičnih žlezah.
Just after starting to breathe in through your mouth, press down on the top of the can to release a puff while still breathing in steadily and deeply. 
Tik potem, ko začnete vdihavati skozi usta, pritisnite na zgornji del pločevinke, da boste sprostili vdih zdravila, medtem ko še naprej enakomerno in globoko dihate.
Place the mouthpiece in your mouth between your teeth and close your lips around it. Do not bite it. 
Dajte ustnik v usta, med zobe, in ustnice dobro stisnite okrog njega.
Do not puncture, break or burn it even if you think it is empty. 
Ne prebadajte je, ne prelamljajte in ne sežigajte, tudi če mislite, da je prazna.
Patients should remove the mouthpiece cover by gently squeezing the sides of the cover and check the mouthpiece inside and outside to see that it is clean. 
Bolnik mora sneti pokrovček ustnika, tako da ga previdno stisne ob straneh; preveriti mora, da je zunanjost in notranjost ustnika čista.
Hold your breath, take the inhaler from your mouth and your finger from the top of the inhaler. 
Zadržite dih, vzemite inhalator iz ust in kazalec umaknite z vrha inhalatorja.
Two puffs twice a day This medicine if not recommended for use in children below 4 years of age. 
Tega zdravila ni priporočljivo uporabljati pri otrocih do 4. leta starosti.
Prolonged treatment of patients with high doses of inhaled corticosteroids may result in adrenal suppression and acute adrenal crisis. 
Dolgotrajno zdravljenje z velikimi odmerki inhaliranih kortikosteroidov lahko klinično zavre delovanje nadledvičnih žlez in povzroči akutno adrenalno krizo.
If using your inhaler for the first time, remove the mouthpiece cover by holding the sides of the inhaler with your thumb and forefinger. 
Če inhalator uporabljate prvič, odstranite pokrovček ustnika, tako da inhalator ob straneh primete s palcem in kazalcem.
GOAL showed more patients treated with Viani achieved asthma control than patients treated with ICS alone and this control was attained at a lower corticosteroid dose. 
Študija GOAL je pokazala, da je obvladanje simptopmov astme doseglo več bolnikov, ki so dobivali Viani, kot bolnikov, ki so dobivali samo IKS (inhalacijski kortikosteroid) in da je bilo to obvladanje doseženo pri nižjih odmerkih kortikosteroida.
Stop using the inhaler when the counter reads 000. 
Ko je na števcu številka 000, inhalator nehajte uporabljati.
To make sure that it works, shake the inhaler well and press the can to release puffs into the air until the counter reads 120. 
Da se boste prepričali, ali inhalator deluje, ga dobro pretresite in pritisnite pločevinko, da boste vdihe sprostili v zrak; to ponavljajte, dokler števec ne pokaže 120.
Well-Controlled asthma was achieved more rapidly with Viani than with ICS alone. 
Z zdravilom Viani je bila dobra nadzorovanost astme dosežena hitreje kot z inhalacijskim kortikosteroidom samim.
You should be standing or sitting whilst using the inhaler. 
Med uporabo inhalatorja stojte ali sedite.
To remove the mouthpiece cover, hold the sides of the inhaler with your thumb and forefinger, squeeze the cover gently and pull apart. 
Za odstranitev pokrovčka ustnika primite inhalator ob straneh s palcem in kazalcem, pokrovček previdno stisnite z obeh strani in ga snemite.
Viani Evohaler and associated names (see Annex I of Opinion) contain salmeterol and fluticasone propionate, a fixed dose combination of the long acting β-agonist (LABA) salmeterol and the inhaled corticosteroid (ICS) fluticasone propionate (FP) indicated in the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate:patients not adequately controlled with inhaled corticosteroids and ‘as needed' inhaled short acting beta-2-agonist or - patients already adequately controlled on both inhaled corticosteroid and longacting beta-2-agonist. 
Zdravilo Viani Evohaler in z njim povezana imena (glejte Dodatek I Mnenja) vsebujejo salmeterol in flutikazon propionat, kombinacijo fiksnih odmerkov dolgo delujočega β-agonista (LABA) salmeterola in inhalacijskega kortikosteroida (ICS) flutikazon propionata (FP), indicirano za običajno zdravljenje astme, kjer je uporaba kombiniranega izdelka (dolgo delujočega β-agonista in inhalacijskega kortikosteroida) ustrezna: - pri bolnikih, pri katerih z inhalacijskimi kortikosteroidi in »po potrebi« z inhalacijskim kratko delujočim beta-2-agonistom ni mogoče doseči zadostnega nadzora bolezni, alipri bolnikih, pri katerih je bilo mogoče že z inhalacijskimi kortikosteroidi in dolgo delujočim beta-2agonistom vzpostaviti zadosten nadzor bolezni.
The time on treatment for 50% of subjects to achieve a first individual Well-Controlled week was 16 days for Viani compared to 37 days for the ICS group. 
Pri 50 % oseb je bil prvi posamezni teden z dobro nadzorovanostjo dosežen po 16 dneh zdravljenja z zdravilom Viani oziroma po 37 dneh zdravljenja z inhalacijskim kortikosteroidom.
The medicine is contained in a pressurised can in a plastic casing with a mouthpiece. 
Zdravilo je v pločevinki pod tlakom, ki ima plastično ohišje in je opremljena z ustnikom.
To clean your inhaler: 
Da boste inhalator očistili:
If patients are going to take a second puff they should keep the inhaler upright and wait about half a minute before repeating steps 2 to 6. 
Če mora narediti še drugi vdih, naj inhalator drži pokonci, počaka približno pol minute in potem ponovi korake od 2 do 6. 8.
Consideration should be given to additional corticosteroid therapies. 
V poštev pride dodatna terapija s kortikosteroidi.
Your doctor will check you regularly for any of these side effects and to make sure you are taking the lowest dose of Viani to control your asthma. 
Zdravnik vas bo redno kontroliral glede teh neželenih učinkov, tako da boste za obvladanje astme dobivali najmanjši odmerek Vianija.
What Viani contains - The active substance(s) are 25 micrograms salmeterol (as xinafoate) and 50, 125 or 250 
Kaj vsebuje zdravilo Viani - Zdravilni učinkovini sta 25 mikrogramov salmeterola (kot ksinafoata) in 50, 125 ali 250
It is recommended that the height of children receiving prolonged treatment with inhaled corticosteroid is regularly monitored. 
Otrokom, ki dolgo uporabljajo inhalirane kortikosteroide, je priporočljivo redno kontrolirati telesno višino.
The non-CFC propellant, Norflurane, has been shown to have no toxic effect at very high vapour concentrations, far in excess of those likely to be experienced by patients, in a wide range of animal species exposed daily for periods of two years. 
Dokazano je, da norfluran, potisni plin brez klorfluoroogljikovodikov, nima nobenih toksičnih učinkov niti pri zelo visokih parnih koncentracijah, veliko višjih od tistih, ki so verjetne pri bolnikih.
- Remove the mouthpiece cover. 
- Odstranite pokrovček ustnika.
The canister contains a white to off white suspension. 
Pločevinka vsebuje suspenzijo bele do kremaste barve.
PHARMACEUTICAL FORM Pressurised inhalation, suspension. 
FARMACEVTSKA OBLIKA Inhalacijska suspenzija pod tlakom.
1 x 120 actuations Inhaler or 3 x 120 actuations Inhaler or 10 x 120 actuations Inhaler - hospital/pharmacy use only (for dispensing purposes) Not all pack sizes may be marketed. 
10 inhalatorjev s 120 sprožitvami - samo za uporabo v bolnišničnih lekarnah Na trgu ni vseh navedenih pakiranj.
Breathe out as far as is comfortable. 
Izdihnite, kolikor je mogoče, ne da bi bilo neprijetno.
Pressurised inhalation, suspension. 
Inhalacijska suspenzija pod tlakom.
CLINICAL PARTICULARS 4.1 Therapeutic indications Viani is indicated in the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled with inhaled corticosteroids and ‘as needed' inhaled short acting beta-2-agonist or patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist. 
KLINIČNI PODATKI 4.1 Terapevtske indikacije Viani je indiciran za redno zdravljenje astme, kadar je primerna uporaba kombiniranega zdravila (dolgodelujočega agonista beta 2 in inhaliranega kortikosteroida): pri bolnikih, nezadostno urejenih z inhaliranimi kortikosteroidi in inhaliranim kratkodelujočim agonistom beta-2, uporabljanim "po potrebi",
Wipe the inside and outside of the mouthpiece and the plastic casing with a dry cloth or tissue. 
Zunanjost in notranjost ustnika ter plastično ohišje obrišite s suho krpico ali papirnatim robčkom.
- Wipe the inside and outside of the mouthpiece and the plastic casing with a dry cloth or tissue. 
- Zunanjost in notranjost ustnika ter plastično ohišje obrišite s suho krpico ali papirnatim robčkom.
Just after starting to breathe in through their mouth, patients should press down on the top of the inhaler to release Viani, while still breathing in steadily and deeply. 
Tik po začetku vdiha skozi usta naj pritisne na vrh pločevinke, da bo sprostil Viani; medtem naj še naprej enakomerno in globoko vdihuje.
Replace the cover by firmly pushing and clicking into position. 
Pokrovček namestite z odločnim pritiskom, da se s klikom zaskoči.
Remove the mouth piece cover. 
Odstranite pokrovček ustnika.
Use of the inhaler: 
Uporaba inhalatorja:
Before using for the first time patients should remove the mouthpiece cover by gently squeezing the sides of the cover, shake the inhaler well, and release puffs into the air until the counter reads 120 to make sure that it works. 
Pred prvo uporabo mora bolnik odstraniti pokrovček ustnika (tako da ga z obeh strani previdno stisne), inhalator dobro pretresti in za preveritev njegovega delovanja sprožiti v zrak toliko odmerkov, da števec pokaže 120.
Hold the inhaler upright with your thumb on the base, below the mouthpiece. 
Inhalator držite pokonci; palec naj bo na spodnji strani, pod ustnikom.
Pooled results across the 3 treatment levels *Well controlled asthma; occasional symptoms or SABA use or less than 80% predicted lung function plus no night-time awakenings, no exacerbations and no side effects enforcing a change in therapy **Total control of asthma; no symptoms, no SABA use, greater than or equal to 80% predicted lung function, no night-time awakenings, no exacerbations and no side effects enforcing a change in therapy. 
*Dobro urejena astma: občasni simptomi ali uporaba KDAB (kratkodelujočega agonista beta) ali manj kot 80 % predvidene pljučne funkcije ter brez prebujanj ponoči, brez poslabšanj in brez neželenih učinkov, ki bi zahtevali spremembo terapije.
Patients should hold the inhaler upright between fingers and thumb with their thumb on the base, below the mouthpiece. 
Inhalator mora držati pokonci med palcem in kazalcem; palec mora biti na spodnji strani, pod ustnikom.
Testing the inhaler: 
Preizkus inhalatorja:
25 micrograms of salmeterol (as salmeterol xinafoate) and 50, 125 or 250 micrograms of fluticasone propionate (delivered from the valve). 
25 mikrogramov salmeterola (kot salmeterolijevega ksinafoata) in 50, 125 ali 250 mikrogramov flutikazonijevega propionata (sproščenega iz zaklopke).
Testing the inhaler 
Preizkus inhalatorja
Angioedema (mainly facial and oropharyngeal oedema), Respiratory symptoms (dyspnoea and/or bronchospasm), Anaphylactic reactions 
Preobčutljivostne reakcije, ki se kažejo kot: kožne preobčutljivostne reakcije angioedem (predvsem edem obraza in orofaringealni edem), dihalni simptomi (dispneja in/ali bronhospazem), anafilaktične reakcije občasno zelo redko
LIST OF EXCIPIENTS Norflurane (HFA 134a) 
Norfluran (HFA 134a)
Patients should shake the inhaler well. 
Inhalator mora dobro pretresti.
You should get a replacement when the counter shows the number 020. 
Ko števec pokaže številko 020, morate dobiti nov inhalator.
If the inhaler has not been used for a week or more remove the mouthpiece cover, the patients should shake the inhaler well and release two puffs into the air. Each time the inhaler is activated the number on the counter will count down by one. 
Če inhalator ni bil uporabljen teden dni ali več, mora bolnik odstraniti pokrovček ustnika, inhalator dobro pretresti in dva odmerka sprožiti v zrak.
Replace the inhaler when the counter reads 000. 
Ko je na števcu številka 000, je inhalator treba zamenjati.
After use patients should always replace the mouthpiece cover by firmly pushing and snapping the cap into position. 
Po uporabi mora bolnik vedno znova namestiti pokrovček ustnika, tako da ga odločno pritisne, da se s klikom zaskoči.
Gently squeeze the sides of the cover and pull apart. 
Previdno stisnite pokrovček z obeh strani in ga snemite.
Each puff provides 25 micrograms of salmeterol (as xinafoate) together with either 50, 125 or 250 micrograms of fluticasone propionate. 
Vsak vdih vsebuje 25 mikrogramov salmeterola (kot ksinafoata) in 50, 125 ali 250 mikrogramov flutikazonijevega propionata.
Patients should consider getting a replacement when the counter shows the number 020. 
Ko števec pokaže številko 020, mora bolnik poskrbeti, da dobi nov inhalator.
While holding their breath, patients should take the inhaler from their mouth and take their finger from the top of the inhaler. 
Nato naj zadrži dih, vzame inhalator iz ust in kazalec umakne z vrha inhalatorja.
- Do not remove the metal can from the plastic casing during cleaning or at any other time. 
- Niti med čiščenjem niti sicer ne jemljite pločevinke iz plastičnega ohišja.
Read the package leaflet before use Inhalation use 
Pred uporabo preberite priloženo navodilo.
Pharmacotherapeutic Group: Adrenergics and other anti-asthmatics. 
Farmakoterapevtska skupina: Adrenergiki in druge učinkovine za obstruktivne pljučne bolezni
Very rarely side effects may occur if you have taken high doses of Viani for a long time and you stop or reduce your dose suddenly. 
Če ste dolgo uporabljali velike odmerke Vianija, pa ga nenadoma nehate uporabljati ali močno zmanjšate odmerek, se lahko v zelo redkih primerih pojavijo neželeni učinki.
- The other ingredient is Norflurane (HFA 134a). 
- Pomožna snov je norfluran (HFA 134a).
Patients should continue holding their breath for as long as is comfortable. 
Bolnik naj izdihne, kolikor je mogoče, ne da bi bilo neprijetno.
If your inhaler has not been used for a week or more remove the mouthpiece cover, shake the inhaler well and release two puffs into the air. Use of the inhaler It is important to start to breathe in as slowly as possible just before using your inhaler. 
Če inhalatorja niste uporabljali teden dni ali več, odstranite pokrovček ustnika, inhalator dobro pretresite in sprostite dva vdiha v zrak.
Patients should be instructed in the proper use of their inhaler (see patient information leaflet) During inhalation, the patient should preferably sit or stand. 
Bolnika morate poučiti o pravilni uporabi inhalatorja (glejte Navodilo za uporabo).
You should ask your doctor for advice before taking Viani whilst you are pregnant or breastfeeding. 
Če ste noseči ali dojite, se pred uporabo Vianija posvetujte z zdravnikom.
Medium dose ICS (>500-1000mcg BDP or equivalent/day) 
brez IKS (samo KDAB) nizkoodmerni IKS ( ≤ 500 mikrogramov BDP ali ekvivalentno/dan srednjeodmerni IKS (> 500 do 1000 mikrogramov BDP ali ekvivalentno/dan) kumulativni rezultati vseh 3 ravni terapije
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM <[Izpolni država članica]> 12.
Two inhalations of 25 micrograms salmeterol and 250 micrograms fluticasone propionate twice daily. 
Dve inhalaciji 25 mikrogramov salmeterola in 250 mikrogramov flutikazonijevega propionata dvakrat na dan.
PHARMACEUTICAL FORM AND CONTENTS Pressurised inhalation, suspension 1 X 120 puffs 
FARMACEVTSKA OBLIKA IN VSEBINA Inhalacijska suspenzija pod tlakom
Two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily. 
Dve inhalaciji 25 mikrogramov salmeterola in 50 mikrogramov flutikazonijevega propionata dvakrat na dan.
A short term trial of Viani may be considered as initial maintenance therapy in adults or adolescents with moderate persistent asthma (defined as patients with daily symptoms, daily rescue use and moderate to severe airflow limitation) for whom rapid control of asthma is essential. 
Pri bolnikih z zmerno, persistentno astmo (tj. z vsakodnevnimi simptomi, vsakodnevno uporabo olajševalnega zdravila in zmerno do hudo obstrukcijo zračnega pretoka), ki bi jim koristilo hitro obvladanje astme, je mogoče poskusiti z uvodnim 12-tedenskim vzdrževalnim zdravljenjem z Vianijem.
In these cases, the recommended initial dose is two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily. 
V takšnem primeru je priporočeni začetni odmerek ena inhalacija 50 mikrogramov salmeterola in 100 mikrogramov flutikazonijevega propionata.
Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: [See Annex I - To be completed nationally] 
Imetnik dovoljenja za promet z zdravilom in izdelovalec [Glejte Dodatek I - Izpolni država članica]
Viani Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension. 
Viani Evohaler in z njim povezana imena (glejte Dodatek I) 25/250 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom.
Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension. 
Viani Evohaler in z njim povezana imena (glejte Dodatek I) 25/125 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom.
Two inhalations of 25 micrograms salmeterol and 125 micrograms fluticasone propionate twice daily. 
Dve inhalaciji 25 mikrogramov salmeterola in 125 mikrogramov flutikazonijevega propionata dvakrat na dan. ali
Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally] 
Viani Evohaler in povezana imena (Glejte Dodatek I) 25/125 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom [Glejte Dodatek I - Izpolni država članica]
Viani Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension. 
Viani Evohaler in z njim povezana imena (glejte Dodatek I) 25/50 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom.
STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 125 micrograms of fluticasone propionate per actuation 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN v enem odmerku je 25 mikrogramov salmeterola (kot ksinafoat) in 125 mikrogramov flutikazonijevega propionata
Viani Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally] 
Viani Evohaler in povezana imena (Glejte Dodatek I) 25/50 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom [Glejte Dodatek I - Izpolni država članica]
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS EVOHALER LABEL 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 50 micrograms of fluticasone propionate per actuation 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN v enem odmerku je 25 mikrogramov salmeterola (kot ksinafoat) in 50 mikrogramov flutikazonijevega propionata
Viani Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally] 
Viani Evohaler in povezana imena (Glejte Dodatek I) 25/250 mikrogramov/odmerek, inhalacijska suspenzija pod tlakom [Glejte Dodatek I - Izpolni država članica]
STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 250 micrograms of fluticasone propionate per actuation 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN v enem odmerku je 25 mikrogramov salmeterola (kot ksinafoat) in 250 mikrogramov flutikazonijevega propionata
The initial starting dose is 2 inhalations of 25 mcg salmeterol and 50 mcg FP twice daily. 
Začetni odmerek sta 2 vdiha 25 µg salmeterola in 50 µg flutikazon propionata dvakrat na dan.
Viani 25/50 micrograms strength is not appropriate in adults and children with severe asthma; it is recommended to establish the appropriate dosage of inhaled corticosteroid before any fixed combination can be used in patients with severe asthma. 
Pri bolnikih s hudo astmo je pred uvedbo katere koli fiksne kombinacije priporočljivo določiti ustrezni odmerek inhalacijskega kortikosteroida.
Keep out of the reach and sight of children 
POGLEDA OTROK